Tech Company Financing Transactions

BioVex Funding Round

Harris & Harris Group, Oxford Finance and Silicon Valley Bank invested in a $13 million Series E funding round for BioVex. The round was announced on 11/15/2007.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series E
Proceeds Purpose
BioVex intends to use the capital to complete its preparations for, and to commence, a Phase III study with its lead product OncoVexGM-CSF for the treatment of melanoma as well as to complete studies in head and neck cancer and pancreatic cancer. The financing will also fund the Company's second program, ImmunoVEXHSV2, a vaccine for genital herpes, through to Phase II.

Company Information

Company Status
Acquired or Merged
Mailing Address
34 Commerce Way
Woburn, MA 01801
Email Address
The Company is developing a new class of potent biologics for the treatmentof cancer and prevention of infectious disease.
BioVex LinkedIn Company Profile
Social Media
BioVex Company Twitter Account
Company News
BioVex News
BioVex on Facebook
BioVex on YouTube

Management Team

Email & Social
Chief Executive Officer
Philip Astley-Sparke
  Philip Astley-Sparke LinkedIn Profile  Philip Astley-Sparke Twitter Account  Philip Astley-Sparke News  Philip Astley-Sparke on Facebook
Chief Financial Officer
Stephen Gorgol
  Stephen Gorgol LinkedIn Profile  Stephen Gorgol Twitter Account  Stephen Gorgol News  Stephen Gorgol on Facebook
Chief Medical Officer
Howard Goldsweig
  Howard Goldsweig LinkedIn Profile  Howard Goldsweig Twitter Account  Howard Goldsweig News  Howard Goldsweig on Facebook
Chief Technical Officer
Robert Coffin
  Robert   Coffin LinkedIn Profile  Robert   Coffin Twitter Account  Robert   Coffin News  Robert   Coffin on Facebook
VP - Bus. Development
Pamela Esposito
  Pamela Esposito LinkedIn Profile  Pamela Esposito Twitter Account  Pamela Esposito News  Pamela Esposito on Facebook
VP - Manufacturing
Paul Bullock
  Paul Bullock LinkedIn Profile  Paul Bullock Twitter Account  Paul Bullock News  Paul Bullock on Facebook
VP - Operations
Timothy Hanke
  Timothy Hanke LinkedIn Profile  Timothy Hanke Twitter Account  Timothy Hanke News  Timothy Hanke on Facebook
VP - Operations
Lance Weed
  Lance Weed LinkedIn Profile  Lance Weed Twitter Account  Lance Weed News  Lance Weed on Facebook
VP - Product Management
Colin Love
  Colin Love LinkedIn Profile  Colin Love Twitter Account  Colin Love News  Colin Love on Facebook
VP - Regulatory Affairs
Anne Woodland
  Anne Woodland LinkedIn Profile  Anne Woodland Twitter Account  Anne Woodland News  Anne Woodland on Facebook



Browse more venture capital transactions:

Prev: 11/15/2007: Apptio venture capital transaction
Next: 11/15/2007: Symbios Medical Products venture capital transaction


Share this article


About Our Venture Capital Transactions Database

Our team works diligently to record every notable VC transaction. All VC database entries reported here are sourced from publicly available VC deal announcements. The information comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary